Blade Air Mobility, Inc. engages in providing air transportation alternatives through a technology-powered and global air mobility platform. It operates through the Passenger and Medical segments. The Passenger segment includes short distance helicopter and amphibious seaplane flights and non-medical jet charter. The Medical segment is involved in the transportation of human organs for transplant. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company